Breaking News Instant updates and real-time market news.

ALXN

Alexion

$123.50

3.18 (2.64%)

14:51
08/29/18
08/29
14:51
08/29/18
14:51

Alexion offices visited by Brazilian tax authorities, Bloomberg says

An Alexion spokesperson told Bloomberg that the company provided documents to Brazil's tax authorities, who visited the company's offices as part of an audit.

  • 12

    Sep

  • 18

    Feb

ALXN Alexion
$123.50

3.18 (2.64%)

08/07/18
STFL
08/07/18
DOWNGRADE
Target $130
STFL
Hold
Alexion downgraded to Hold from Buy at Stifel
Stifel transferred coverage of Alexion to analyst Paul Matteis, who set a Hold rating and $130 price target on the shares, down from the firm's prior Buy rating. He has difficulty envisioning significant upside to mid-to-long-term consensus expectations given his worries about the risks associated with an increasingly challenging European payor environment and the breadth of drug development ongoing in the complement space, Matteis tells investors.
07/26/18
PIPR
07/26/18
NO CHANGE
PIPR
Piper Jaffray would be buyers on Alexion weakness
Piper Jaffray analyst Christopher Raymond said in a research note that he believes the pressure in Alexion is "more macro-driven than company specific." He noted that with a solid Q2 beat and FY18 raise, along with continued pipeline progress and increased certainty with regard to the complement inhibition franchise's revenue tail, there is much to like with this name, and he would recommend buying the name on weakness. He kept an Overweight rating and $170 price target on Alexion shares.
07/26/18
EVER
07/26/18
NO CHANGE
Target $158
EVER
Outperform
Alexion price target raised to $158 from $150 at Evercore ISI
Evercore ISI analyst Josh Schimmer said Alexion is "consistently conservative" on guidance and he wouldn't be surprised to see the company raise its outlook again in Q3 as it did with its Q2 report. He also noted that company reported "slight" delays for 1210 and its Wilson's program. Following the report, he raised his price target on Alexion to $158 and reiterated his Outperform rating on the shares.
06/15/18
OPCO
06/15/18
NO CHANGE
OPCO
Outperform
Large-cap biotech fundamentals slowly improving, says Oppenheimer
Ahead of Q2 biotech earnings starting in mid-July, Oppenheimer analyst Hartaj Singh tells investors in a research note that large-cap fundamentals and sector sentiment are "slowly but surely" improving. Improving fundamentals indicate that large-cap biotech results could outperform in Q2, with Gilead (GILD), Alexion (ALXN) and Vertex (VRTX) leading the charge. Singh called out Vertex as "one of our favorite large-cap biotech names," and also says he believes the negative sentiment around Regeneron (REGN) "might be peaking." Singh, who has Outperform ratings on Alexion and Vertex and a Perform rating on Gilead and Regeneron, says he is "cautiously bullish" on the sector.

TODAY'S FREE FLY STORIES

14:20
12/18/18
12/18
14:20
12/18/18
14:20
General news
Canada CPI preview »

Canada CPI preview:…

TCEHY

Tencent

$0.00

(0.00%)

, DIS

Disney

$109.75

-0.88 (-0.80%)

14:18
12/18/18
12/18
14:18
12/18/18
14:18
Periodicals
'PUBG' on mobile has as many total users as 'Fortnite,' Verge reports »

The mobile version of…

TCEHY

Tencent

$0.00

(0.00%)

DIS

Disney

$109.75

-0.88 (-0.80%)

KKR

KKR

$19.89

0.09 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 11

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/18/18
12/18
14:17
12/18/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/18/18
12/18
14:16
12/18/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDR

McDermott

$6.72

-0.39 (-5.49%)

14:05
12/18/18
12/18
14:05
12/18/18
14:05
Options
McDermott call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$163.24

-0.19 (-0.12%)

14:02
12/18/18
12/18
14:02
12/18/18
14:02
Hot Stocks
General Dynamics unit awarded Department of Education contract »

General Dynamics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

APHA

Aphria

$5.87

0.43 (7.90%)

, TLRY

Tilray

$76.52

10.63 (16.13%)

14:00
12/18/18
12/18
14:00
12/18/18
14:00
Hot Stocks
Citron touts cannabis name Aphria again, sees shares above $8 by year-end »

Shares of Aphria (APHA)…

APHA

Aphria

$5.87

0.43 (7.90%)

TLRY

Tilray

$76.52

10.63 (16.13%)

ACB

Aurora Cannabis

$5.57

0.03 (0.54%)

MO

Altria Group

$51.40

-0.97 (-1.85%)

NVS

Novartis

$85.56

-0.24 (-0.28%)

CRON

Cronos Group

$11.50

0.375 (3.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 07

    Feb

STZ

Constellation Brands

$172.45

-3.61 (-2.05%)

13:55
12/18/18
12/18
13:55
12/18/18
13:55
Options
Constellation Brands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

MU

Micron

$34.81

0.92 (2.71%)

, UMC

UMC

$1.81

-0.005 (-0.28%)

13:50
12/18/18
12/18
13:50
12/18/18
13:50
On The Fly
Fly Intel: What to watch for in Micron's earnings report »

Micron (MU) is scheduled…

MU

Micron

$34.81

0.92 (2.71%)

UMC

UMC

$1.81

-0.005 (-0.28%)

INTC

Intel

$48.04

0.95 (2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 04

    Jan

  • 07

    Jan

  • 08

    Jan

VOD

Vodafone

$19.88

-0.13 (-0.65%)

13:48
12/18/18
12/18
13:48
12/18/18
13:48
Periodicals
Vodafone preparing to remove PwC as auditor, Sky News reports »

Vodafone is preparing to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,057.23

30.69 (2.99%)

, GOOG

Alphabet

$1,046.01

28.41 (2.79%)

13:40
12/18/18
12/18
13:40
12/18/18
13:40
Periodicals
Search engine startup claims Google still blocking competition, TechCrunch says »

The European Commission…

GOOGL

Alphabet Class A

$1,057.23

30.69 (2.99%)

GOOG

Alphabet

$1,046.01

28.41 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

KMX

CarMax

$60.38

0.11 (0.18%)

13:40
12/18/18
12/18
13:40
12/18/18
13:40
Options
7X average daily option volume in CarMax driven by an earnings hedge »

7X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

  • 31

    Jan

  • 01

    Feb

BIDU

Baidu

$169.94

0.03 (0.02%)

13:35
12/18/18
12/18
13:35
12/18/18
13:35
Hot Stocks
Unity Technologies, Baidu partner to develop autonomous vehicle simulation »

Unity Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$131.11

2 (1.55%)

13:32
12/18/18
12/18
13:32
12/18/18
13:32
Periodicals
J&J settles woman's talc cancer case for over $1.5M, Bloomberg reports »

Johnson & Johnson,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 27

    Jan

ORGS

Orgenesis

$4.84

-0.11 (-2.22%)

13:31
12/18/18
12/18
13:31
12/18/18
13:31
Hot Stocks
Orgenesis announces collaboration with MangoGen Pharma »

Orgenesis announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNN

Smith & Nephew

$36.67

-0.38 (-1.03%)

13:27
12/18/18
12/18
13:27
12/18/18
13:27
Hot Stocks
Smith & Nephew buys Ceterix Orthopaedics for $50M initial consideration »

Smith & Nephew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$81.62

1.12 (1.39%)

13:26
12/18/18
12/18
13:26
12/18/18
13:26
Hot Stocks
Albemarle higher after Hedgeye names new Best Idea Long »

Shares of Albemarle are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTWO

Take-Two

$104.09

1.87 (1.83%)

, ATVI

Activision Blizzard

$47.54

0.45 (0.96%)

13:24
12/18/18
12/18
13:24
12/18/18
13:24
On The Fly
Game On: Wedbush's Pachter says 'Red Dead 2' performing better than he expected »

SUCCESS OF 'RED DEAD 2':…

TTWO

Take-Two

$104.09

1.87 (1.83%)

ATVI

Activision Blizzard

$47.54

0.45 (0.96%)

EA

Electronic Arts

$81.22

2.01 (2.54%)

NTDOY

Nintendo

$0.00

(0.00%)

MSFT

Microsoft

$104.06

1.08 (1.05%)

SNE

Sony

$50.06

-0.425 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

  • 03

    Mar

  • 04

    Mar

13:20
12/18/18
12/18
13:20
12/18/18
13:20
Options
Put buying in PHLX Gold and Silver Mining Index as the sector sees strength »

Put buying in PHLX Gold…

APHA

Aphria

$5.98

0.54 (9.93%)

13:18
12/18/18
12/18
13:18
12/18/18
13:18
Hot Stocks
Citron expects 'major partnership or total buyout' soon for Aphria 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$6.01

0.57 (10.48%)

, IGC

India Globalization Capital

$0.00

(0.00%)

13:17
12/18/18
12/18
13:17
12/18/18
13:17
Hot Stocks
Citron mentions Aphria positively again, says 'everything changed' in cannabis 

Reference Link

APHA

Aphria

$6.01

0.57 (10.48%)

IGC

India Globalization Capital

$0.00

(0.00%)

CANN

General Cannabis

$0.00

(0.00%)

CGC

Canopy Growth

$29.00

-0.365 (-1.24%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

CRON

Cronos Group

$11.64

0.52 (4.68%)

TLRY

Tilray

$74.39

8.5 (12.90%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

ACB

Aurora Cannabis

$5.55

0.01 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$6.01

0.57 (10.48%)

13:17
12/18/18
12/18
13:17
12/18/18
13:17
Periodicals
Breaking Periodicals news story on Aphria »

Citron Research sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/18/18
12/18
13:17
12/18/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/18/18
12/18
13:16
12/18/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$24.98

-0.32 (-1.26%)

13:15
12/18/18
12/18
13:15
12/18/18
13:15
Options
Nielsen put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.